Araujo, J. C., Trudel, G. C., & Paliwal, P. (2013). Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel. Dove Medical Press.
Chicago Style CitationAraujo, John C., Geralyn C. Trudel, i Prashni Paliwal. Long-term Use of Dasatinib in Patients With Metastatic Castration-resistant Prostate Cancer After Receiving the Combination of Dasatinib and Docetaxel. Dove Medical Press, 2013.
Cita MLAAraujo, John C., Geralyn C. Trudel, i Prashni Paliwal. Long-term Use of Dasatinib in Patients With Metastatic Castration-resistant Prostate Cancer After Receiving the Combination of Dasatinib and Docetaxel. Dove Medical Press, 2013.
Atenció: Aquestes cites poden no estar 100% correctes.